Bevacizumab (Avastin) Use in Neovascular Glaucoma, and Beyond

E-ISSN： 0975-1947|1|2|26-29

ISSN： 0974-0333

Source： Journal of Current Glaucoma Practice, Vol.1, Iss.2, 2007-09, pp. : 26-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Topical Bevacizumab for Neovascular Glaucoma: A Pilot Study

Pharmacology, Vol. 93, Iss. 3-4, 2014-02 ,pp. : 108-112

Karger

Access to resources Recommend Favorite

Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma

Ophthalmologica, Vol. 226, Iss. 2, 2011-05 ,pp. : 51-56

Karger

Access to resources Recommend Favorite

Bevacizumab (Avastin®)

By Shimoyama Tatsu

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 523-530

Sunmedia

Access to resources Recommend Favorite

Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma

Journal of Current Glaucoma Practice, Vol. 10, Iss. 2, 2016-05 ,pp. : 39-48

Jaypee Infomedia

Access to resources Recommend Favorite

Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 370-375

Karger

Access to resources Recommend Favorite